PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22382633-8	2012	PegIFNalpha-2a was more effective than PegIFNalpha-2b (81.8 vs. 62.7%, P = 0.014) in IL28B TT genotype patients, despite similarly low SVR rates in patients with TG or GG genotypes (36.4 vs. 35.9%).	pegifnalpha	0-11	interferon lambda 3	Homo sapiens	85-90